Prescription GLP-1 receptor agonists may be indicated for adults with type 2 diabetes not meeting glycemic targets, those with established cardiovascular disease or chronic kidney disease, or individuals with obesity and weight-related complications when lifestyle interventions prove insufficient
These patients start twice-weekly dosing, lose track of their schedule, miss doses, and either discontinue treatment or contact their provider for help getting back on track
Supplementary Video 2 does not include morphs for the peptide or extracellular domain because one extreme frame from component 1 showed poorly resolved density in these regions
doi:10.1016/j.ceca.2012.02.008, PMID: 22480931 Jin M, Yaung J, Kannan R, He S, Ryan SJ, Hinton DR (2005) Hepatocyte growth factor protects RPE cells from apoptosis induced by glutathione depletion